Description
The study shows upregulation of COX17, NDUFB1, and ATP5MC1 as a compensatory response to GFM1 loss, but the signaling pathways triggering this response remain unknown. Understanding these mechanisms could reveal therapeutic targets for mitochondrial dysfunction.
Gap type: unexplained_observation Source paper: Evaluation of GFM1 mutations pathogenicity through in silico tools, RNA sequencing and mitophagy pahtway in GFM1 knockout cells. (2025, International journal of biological macromolecules, PMID:39952508)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:36.536938+00:00”, “resolution_summary”: “Resolved by hypothesis h-alsmnd-c5d2e9c2edeb: SFPQ Paralog Displacement Triggers Cryptic Polyadenylation and Global RNA Stability Loss in ALS Motor Neurons. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260410-181258-df5eee45.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-alsmnd-c5d2e9c2edeb”, “title”: “SFPQ Paralog Displacement Triggers Cryptic Polyadenylation and Global RNA Stability Loss in ALS Motor Neurons”, “score”: 0.228, “reason”: “8 token overlaps; entity overlap: rna”, “analysis_id”: null, “target_gene”: “SFPQ,NONO,PSP1,TARDBP,poly(A) machinery,CPSF,PABPN1”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.864139, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“36414621”, “40369342”, “41120750”, “41836882”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-181258-df5eee45”, “title”: “The study shows that OB microglia phagocytose LC axons before amyloid plaque formation, but the molecular signals that mark these axons for destruction are unknown. Understanding this mechanism could reveal early therapeutic targets to prevent noradrenergic denervation.\n\nGap type: unexplained_observation\nSource paper: Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease. (2025, Nature communications, PMID:40781079)”, “score”: 0.472, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-181258-df5eee45”, “quality_score”: 0.7, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-041428-4c4414ad_task_9aae8fc5”, “title”: “The study shows stress granules are dynamic and reversible assemblies, but in neurodegeneration they become pathological and persistent. The molecular mechanisms governing this transition from physiological to pathological states remain unexplained, yet understanding this could reveal therapeutic targets.\n\nGap type: unexplained_observation\nSource paper: G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules. (2020, Cell, PMID:32302571)”, “score”: 0.43, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041428-4c4414ad”, “quality_score”: 0.843, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a_task_73907230”, “title”: “The study shows P2RY12 regulates VSMC foam cell formation but doesn’t explain what controls P2RY12 expression or activation in VSMCs during disease progression. Understanding these upstream regulators could reveal new therapeutic targets for vascular neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. (2021, Autophagy, PMID:32160082)”, “score”: 0.409, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a”, “quality_score”: 0.661, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-004616”, “title”: “The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeutic targets for MS neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. (None, None, PMID:33603230)”, “score”: 0.405, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b”, “quality_score”: 0.92, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-005103”, “title”: “The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeutic targets for MS neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. (None, None, PMID:33603230)”, “score”: 0.405, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b”, “quality_score”: 0.68, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}